Olivier Danos
2018
In 2018, Olivier Danos earned a total compensation of $1.6M as Chief Scientific Officer at Regenxbio, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,568 |
|---|---|
| Option Awards | $982,739 |
| Salary | $409,000 |
| Other | $14,462 |
| Total | $1,613,769 |
Danos received $982.7K in option awards, accounting for 61% of the total pay in 2018.
Danos also received $207.6K in non-equity incentive plan, $409K in salary and $14.5K in other compensation.
Rankings
In 2018, Olivier Danos' compensation ranked 6,815th out of 14,244 executives tracked by ExecPay. In other words, Danos earned more than 52.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,815 out of 14,244 | 52nd |
Division Manufacturing | 2,607 out of 5,759 | 55th |
Major group Chemicals And Allied Products | 980 out of 2,122 | 54th |
Industry group Drugs | 822 out of 1,811 | 55th |
Industry Biological Products, Except Diagnostic Substances | 158 out of 339 | 53rd |
Source: SEC filing on April 11, 2019.
Danos' colleagues
We found four more compensation records of executives who worked with Olivier Danos at Regenxbio in 2018.